Public Profile

Lonza

Lonza Group AG, commonly referred to as Lonza, is a leading global provider of integrated solutions for the pharmaceutical, biotechnology, and specialty ingredients sectors. Headquartered in Switzerland (CH), Lonza operates extensively across Europe, North America, and Asia, delivering innovative products and services that cater to diverse industry needs. Founded in 1897, Lonza has achieved significant milestones, including advancements in cell and gene therapy manufacturing. The company is renowned for its high-quality contract development and manufacturing services (CDMO), as well as its extensive portfolio of active pharmaceutical ingredients (APIs) and custom manufacturing solutions. Lonza's commitment to sustainability and cutting-edge technology positions it as a market leader, consistently recognised for its contributions to the life sciences and healthcare industries.

DitchCarbon Score

How does Lonza's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

73

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Lonza's score of 73 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.

99%

Let us know if this data was useful to you

Lonza's reported carbon emissions

In 2024, Lonza reported total carbon emissions of approximately 2,334,000,000 kg CO2e, with Scope 1 emissions at about 319,000,000 kg CO2e, Scope 2 emissions (market-based) at approximately 137,000,000 kg CO2e, and a significant Scope 3 contribution of about 1,878,000,000 kg CO2e. This represents a slight decrease from 2023, where total emissions were about 2,459,000,000 kg CO2e. Lonza has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by 2030, using a 2021 baseline. Additionally, they target a 50% reduction in energy and waste intensity by 2030 compared to 2018 levels. These initiatives are part of their broader strategy to achieve net-zero emissions by 2050 or earlier. The company has also committed to ensuring that 79% of its suppliers, based on emissions from purchased goods and services, capital goods, and upstream transportation and distribution, will have science-based targets by 2028. This comprehensive approach underscores Lonza's commitment to sustainability and reducing its carbon footprint across its operations and supply chain.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2018201920202021202220232024
Scope 1
574,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
348,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
-
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Lonza's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Lonza is in CH, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Lonza is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Celanese

US
Chemicals nec
Updated 3 days ago

Evonik

DE
Chemicals nec
Updated about 22 hours ago

Asymchem Laboratories

CN
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Pharmaron Beijing

CN
Research and development services (73)
Updated 3 days ago

Anupam Rasayan India

IN
Chemicals nec
Updated 3 days ago

King-Friend Biochemical Pharmaceutical Co. Ltd.

CN
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers